PreveCeutical Medical Inc (18H) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.070x

Based on the latest financial reports, PreveCeutical Medical Inc (18H) has a cash flow conversion efficiency ratio of 0.070x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-520.46K ≈ $-608.47K USD) by net assets (€-7.39 Million ≈ $-8.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PreveCeutical Medical Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

PreveCeutical Medical Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how PreveCeutical Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PreveCeutical Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PreveCeutical Medical Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
REDSUN PROPERTIES GROUP F:0RJ	N/A
Tarachi Gold Corp F:4RZ	-0.017x
Grupo Vasconia S.A.B MX:VASCONI	0.006x
Twin Vee Powercats Co NASDAQ:VEEE	-0.096x
Weaccess Group SA PA:MLWEA	0.230x
BPH Global Ltd AU:BP8	0.413x
Earthworks Industries Inc V:EWK	-0.004x
Usha Resources Ltd V:USHA	0.085x

Annual Cash Flow Conversion Efficiency for PreveCeutical Medical Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of PreveCeutical Medical Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see PreveCeutical Medical Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-6.64 Million ≈ $-7.76 Million	€-426.69K ≈ $-498.85K	0.064x	+25.09%
2023-12-31	€-5.78 Million ≈ $-6.76 Million	€-296.97K ≈ $-347.19K	0.051x	-47.18%
2022-12-31	€-4.64 Million ≈ $-5.42 Million	€-450.99K ≈ $-527.25K	0.097x	-6.35%
2021-12-31	€-4.10 Million ≈ $-4.80 Million	€-426.39K ≈ $-498.49K	0.104x	+679.67%
2020-12-31	€-3.60 Million ≈ $-4.21 Million	€64.59K ≈ $75.52K	-0.018x	-108.09%
2019-12-31	€-4.49 Million ≈ $-5.25 Million	€-993.94K ≈ $-1.16 Million	0.222x	-93.32%
2018-12-31	€-2.29 Million ≈ $-2.67 Million	€-7.57 Million ≈ $-8.85 Million	3.314x	-73.46%
2017-12-31	€-344.34K ≈ $-402.57K	€-4.30 Million ≈ $-5.03 Million	12.485x	+181.02%
2016-12-31	€-296.06K ≈ $-346.13K	€-1.32 Million ≈ $-1.54 Million	4.443x	--

About PreveCeutical Medical Inc

F:18H Germany Biotechnology

Market Cap

$3.34 Million

€2.85 Million EUR

Market Cap Rank

#29209 Global

#2547 in Germany

Share Price

€0.01

Change (1 day)

-54.55%

52-Week Range

€0.01 - €0.03

All Time High

€0.13